Sign in

David Tobias

CEO at CBDS
Board
Since January 9, 2019
Age
72 years
Tenure
Joined the company as a director in 2014, assumed the role of President on 03-29-2016, was appointed CEO on 01-09-2019, and later took on the CFO role in Q4 2022.

Also at CBDS

About

David Tobias has built an extensive career in the cannabis industry, working in progressively responsible roles. He began his career as a Sales Manager for a custom builder before moving into executive roles, including Vice President at Medical Marijuana Inc. and President at Hemp, Inc. and Wild Earth Naturals, Inc..

He joined CBDS as a director in 2014 and later assumed higher responsibilities within the company. On 03-29-2016 he joined as President and was promoted to CEO on 01-09-2019, eventually also serving as CFO in Q4 2022. His leadership and strategic vision have been instrumental during periods of significant change within the organization.

Beyond his roles at CBDS, his career reflects a dedicated involvement in merging business strategies and operational improvements across multiple cannabis companies. His expertise in executive leadership and entrepreneurial experience has contributed to guiding the company through pivotal transitions, underscoring a professional journey marked by adaptability and forward-thinking management.

$CBDS Performance Under David Tobias

Past Roles

OrganizationRoleDate RangeDetails
Cannabis Sativa, Inc. Chief Financial Officer (CFO) 4th fiscal quarter 2022 Held prior to becoming CEO
Cannabis Sativa, Inc. President March 29, 2016 - January 9, 2019 Former role before CEO appointment
Cannabis Sativa, Inc. Director 2014 - Prior to CEO appointment N/A
Wild Earth Naturals, Inc. President Since May 2013 - Pre-CBDS N/A
Hemp, Inc. President August 2011 - January 9, 2014 N/A
Medical Marijuana Inc. Vice President October 2009 - May 2011 Played a key role in facilitating the merger between CannaBank and Medical Marijuana, Inc.
Xcite Homes Sales Manager October 2008 - August 2009 Tulsa custom builder

External Roles

OrganizationRoleDate RangeDetails
THC Pharmaceuticals Inc. Director N/A Ticker: CBDG

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Salary$178,125 AnnualStandard fixed annual salary
Stock Awards$0 N/ANo stock awards reported
Director Fees$18,750 AccruedAccrued as stock payable
Consulting Fees$187,500 AccruedAccrued for consulting services
Notes Payable$47,920 principal + $13,779 interest Due December 31, 2023Loaned amount: $38,400 originally; Outstanding balance at Dec 31, 2023: $47,920; Interest accrued: $13,779; 5% per annum rate

Performance Compensation

Data from  FY 2023

No information available on performance compensation for 2023